There is something new about ddn...Our front cover this month shows a change, but it is more about ddn continuing to evolve with the news of the changing technology in pharma, biotech and life-science research
A knowledge-based economy cannot thrive with frictions imposed by millennium-old constraints. At the limits where no one has a degree or
everyone has a degree, the consequences are clearly dire. Too much of a good thing is a bad thing, and perhaps that’s where we are today in the United
Rapid, informative and inexpensive DNA variation annotation represents the future for much of medical research, and will continue to serve as the basis for significant technology development in academic and industry settings.